Bemærk: Kan ikke leveres før jul.
The only comprehensive overview of the molecular basis, clinical features and potential treatment of the genetic disorder tuberous sclerosis, which affects some 50,000 people in the US alone. The editors are leading experts in research and treatment of the disease.